Skip to content

Clinical trials

Metabolism, Inborn Errors trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20141
20151
20172
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.4
Kastle Therapeutics, LLC2
Akcea Therapeutics1
Alexion Pharmaceuticals, Inc.1
HemoShear Therapeutics1
Regeneron Pharmaceuticals1
Shire1
Sumitomo Pharma Switzerland GmbH1
Synlogic1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors14
Genetic Diseases, Inborn12
Metabolic Diseases10
Lipid Metabolism Disorders6
Infant, Newborn, Diseases4
Lipid Metabolism, Inborn Errors4
Dyslipidemias3
Hyperlipidemias3
Hyperlipoproteinemias3
Lysosomal Storage Diseases3

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.